Dextromethorphan Pediatric Acute Cough Study

PHASE4TerminatedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

February 25, 2016

Primary Completion Date

March 19, 2020

Study Completion Date

March 19, 2020

Conditions
Cough
Interventions
DRUG

Dextromethorphan Hydrobromide

15 mg/ 10 mL: 10 mL of Dextromethorphan Hydrobromide

DRUG

Placebo

10 mL Placebo

DEVICE

Cough recording device

FDA approved device validated for use in adults and children

Trial Locations (18)

29118

Carolina Ear, Nose & Throat Clinic/CENTRI Inc., Orangeburg

29414

Coastal Pediatric Associates, Charleston

29464

Coastal Pediatric Associates, Mt. Pleasant

32720

Avail Clinical Research, LLC, DeLand

32806

Clinical Associates of Orlando LLC, Orlando

40004

Kentucky Pediatric/Adult Research, Bardstown

40243

All Children Pediatrics, Louisville

40291

Bluegrass Clinical Research, Inc, Louisville

44122

Rapid Medical Research, Inc, Cleveland

57049

Meridian Clinical Research, LLC, Dakota Dunes

68134

Meridian Clinical Research LLC, Omaha

68504

Midwest Children's Health Research Institute, Lincoln

70006

MedPharmics, LLC, Metairie

76104

Texas Health Care, PLLC, Fort Worth

Ventavia Research Group, LLC, Fort Worth

83221

Elite Clinical Trials LLLP, Blackfoot

83642

Advanced Clinical Research, Meridian

84088

Advanced Clinical Research, West Jordan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02651116 - Dextromethorphan Pediatric Acute Cough Study | Biotech Hunter | Biotech Hunter